Who Paid My Doc Search
Menu
Product Program year 2022 Source: CMS Open Payments

Recell

Device Mechanical and Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator

PDI 00851707004149

Open in the dashboard

General payments

$211,947

665 payments

Research payments

$4,730,106

113 payments

Through program year 2022, $211,947 in general payments and $4,730,106 in research payments were reported against Recell (Mechanical and Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2022 General $9,048 105
2022 Research $2,738,453 66
2021 General $202,899 560
2021 Research $1,991,652 47

Breakdown

Who paid General payments · program years 2021–2022
  1. Avita Medical Americas, LLC $211,947 665 payments
Top recipients General payments · program year 2022
  1. John Harvin Surgery · Houston, TX $1,154 13% · 20 payments
  2. Jeffrey Carter Trauma Surgery · New Orleans, LA $883 10% · 9 payments
  3. Nicole Bernal Surgical Critical Care · Columbus, OH $610 7% · 10 payments
  4. Haig Yenikomshian Plastic Surgery · Los Angeles, CA $357 4% · 3 payments
  5. Brian Draper Surgery · Springfield, MO $311 3% · 3 payments

The top 5 of 36 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Surgery $2,661 31% · 9 practitioners
  2. Dermatology $1,502 18% · 8 practitioners
  3. Surgical Critical Care Surgery $1,403 16% · 5 practitioners
  4. Trauma Surgery Surgery $1,164 14% · 3 practitioners
  5. Plastic Surgery $551 6% · 2 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $1,934 21% · 5 recipients
  2. New York $1,151 13% · 6 recipients
  3. California $1,100 12% · 5 recipients
  4. Ohio $1,066 12% · 3 recipients
  5. Louisiana $1,009 11% · 2 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

Records

665 general · 113 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record